Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections

Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections

Background. Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often l...

Full description

Bibliographic Details
Main Authors: Zoe A. Stewart, MD, PhD, Jeffrey Stern, MD, Nicole M. Ali, MD, Harmit S. Kalia, DO, Karen Khalil, PharmD, Srijana Jonchhe, PharmD, Elaina P. Weldon, MSN, Rebecca A. Dieter, PharmD, Tyler C. Lewis, PharmD, Nur Funches, BS, Sudara Crosby, AA, Monique Seow, HSD, Jonathan C. Berger, MD, Nabil N. Dagher, MD, Bruce E. Gelb, MD, Anthony C. Watkins, MD, Nader Moazami, MD, Deane E. Smith, MD, Zachary N. Kon, MD, Stephanie H. Chang, MD, Alex Reyentovich, MD, Luis F. Angel, MD, Robert A. Montgomery, MD, PhD, Bonnie E. Lonze, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-10-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001222

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001222

Similar Items